Codex biosolutions:1203128 [24-000295]
Ended Purchase Order Awarded
- Contract number
- 75N95024P00026
- Awardee
-
Dexorgen Inc. UEI ZNUMJ4FKRC19
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $29,400
Award facts
- Contract value 100% obligated
- $29,400.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Montgomery Village, MD 20879, USA
Award details come from SAM.gov/FPDS.
About this award
This is a $29,400 firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Dexorgen Inc., doing business as Codex Biosolutions Inc. Codex Biosolutions is a minority-owned, small disadvantaged business that specializes in advanced biotechnological research, particularly in cell line development, genetic engineering, and translational science support. The contract, which has no set-aside designation, is for the company to provide specialized scientific services related to COVID-19 research, such as constructing cell lines expressing SARS-CoV-2 spike protein variants and developing pseudoparticles for viral entry inhibition assays. Codex Biosolutions has consistently secured federal contract awards from multiple NIH agencies, including NCATS, the National Institute of Allergy and Infectious Diseases (NIAID), and the National Institute on Drug Abuse.
Quick answers
Who was awarded contract 75N95024P00026?
75N95024P00026 was awarded to Dexorgen Inc. by National Institute on Drug Abuse (National Institutes of Health) on November 21, 2023.
How much is contract 75N95024P00026 worth?
The government has obligated $29,400 on 75N95024P00026.
Which agency awarded contract 75N95024P00026?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024P00026, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95024P00026 competed?
The extent of competition for 75N95024P00026 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award